Skip to main content

Advertisement

Log in

Microbiologist in the Clinic: Postmenopausal Woman with Chronic OAB and Positive Urine Culture

  • Clinical Opinion
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

In this second episode of the Microbiologist in the Clinic series, clinicians and laboratory scientists share their perspectives about a 75-year-old woman who was diagnosed with asymptomatic bacteriuria based on positive urine cultures. The patient and her GP are concerned about this laboratory finding as the patient will become immunosuppressed with planned chemotherapy. The patient has had an overactive bladder (OAB) for approximately 20 years, with good control of her urinary urgency and frequency (no incontinence) with a stable dose of OAB medication. The challenges of this clinical presentation are discussed, with evidence for evaluation and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abraham SN, Miao Y. The nature of immune responses to urinary tract infections. Nat Rev Immunol. 2015;15(10):655–63. https://doi.org/10.1038/nri3887.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infect. 2009;58(2):91–102. https://doi.org/10.1016/j.jinf.2008.12.009.

    Article  PubMed  Google Scholar 

  3. Nielsen KL, Dynesen P, Larsen P, Frimodt-Møller N. Faecal Escherichia coli from patients with E. coli urinary tract infection and healthy controls who have never had a urinary tract infection. J Med Microbiol. 2014;63(4):582–9. https://doi.org/10.1099/jmm.0.068783-0.

    Article  CAS  PubMed  Google Scholar 

  4. Hayes BW, Abraham SN. Innate immune responses to bladder infection. Microbiol Spectr. 2016;4(6). https://doi.org/10.1128/microbiolspec.uti-0024-2016.

  5. Sarkissian Milner CA, Alteri CJ, Mobley HLT. UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens. Vaccine. 2019;37(35):4937–46. https://doi.org/10.1016/j.vaccine.2019.07.031.

    Article  CAS  Google Scholar 

  6. Wu J, Hayes BW, Phoenix C, et al. A highly polarized TH2 bladder response to infection promotes epithelial repair at the expense of preventing new infections. Nat Immunol. 2020;21(6):671–83. https://doi.org/10.1038/s41590-020-0688-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Chieng CCY, Kong Q, Liou NSY, Khasriya R, Horsley H. The clinical implications of bacterial pathogenesis and mucosal immunity in chronic urinary tract infection. Mucosal Immunol. 2023;16(1):61–71. https://doi.org/10.1016/j.mucimm.2022.12.003.

    Article  CAS  PubMed  Google Scholar 

  8. Brubaker L. Forming consensus to advance urobiome research. mSystems. 2021;6(4):164971.

    Article  Google Scholar 

  9. Antoniou V, Somani BK. Topical and oral oestrogen for recurrent urinary tract infection—evidence-based review of literature, treatment recommendations, and correlation with the European Association of Urology guidelines on urological infections. Eur Urol Focus. 2022;8(6):1768–74.

    Article  PubMed  Google Scholar 

  10. Brubaker L, Chai T, Horsley H, Khasriya R, Moreland RB, Wolfe AJ. Tarnished gold–the “standard” urine culture: reassessing the characteristics of a criterion standard for detecting urinary microbes. Front Urol. 2023. https://doi.org/10.3389/fruro.2023.1206046.

    Article  Google Scholar 

  11. Harding C, Chadwick T, Homer T, Ali A. Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT. Health Technol Assess. 2022;26(23):1–172.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Schirrmacher V. From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (review). Int J Oncol. 2019;54(2):407–19. https://doi.org/10.3892/ijo.2018.4661.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to conceptualization (as part of a 2021 IUGA workshop) and writing all drafts, in addition to review and editing.

Corresponding author

Correspondence to Linda Brubaker.

Ethics declarations

Ethical approval

As no protected health information was included in this conversational commentary, no ethical approval was sought or required.

Conflicts of interest

L.B.: editorial stipends from JAMA and Up To Date; H.H.: no disclosures; H.K.: no disclosures; A.J.W.: advisory boards at Urobiome Therapeutics and Pathnostics and funding from NIH, Craig H. Neilsen Foundation, Pathnostics, and VB Tech.

Additional information

Handling Editor: Annette Kuhn

Editor in Chief: Kaven Baessler

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brubaker, L., Horsley, H., Khasriya, R. et al. Microbiologist in the Clinic: Postmenopausal Woman with Chronic OAB and Positive Urine Culture. Int Urogynecol J (2024). https://doi.org/10.1007/s00192-024-05819-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00192-024-05819-y

Keywords

Navigation